1950
DOI: 10.1126/science.111.2874.85
|View full text |Cite
|
Sign up to set email alerts
|

Terramycin, a New Antibiotic

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
61
0
5

Year Published

1950
1950
2017
2017

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 254 publications
(67 citation statements)
references
References 7 publications
1
61
0
5
Order By: Relevance
“…The results in general are similar to those described by Fildes and Whitaker (1948), Finlay et al (1950), Bryson and Demerec (1950), Hobby and Lenert (1950), Cavalli (1952), Welsch (1952), and others (of. Third Symposium of…”
supporting
confidence: 79%
“…The results in general are similar to those described by Fildes and Whitaker (1948), Finlay et al (1950), Bryson and Demerec (1950), Hobby and Lenert (1950), Cavalli (1952), Welsch (1952), and others (of. Third Symposium of…”
supporting
confidence: 79%
“…1). The dimethyamino substituent is easy to be protonated in acid media [15] and the phenolic substituent may be oxidized [16]. Figure 2 shows the anodic response of TC at the acetylene black electrode in Mcllvaine buffer solution (pH 2.5) after accumulation at open circuit for 150 s. No apparent redox response is observed in the blank buffer solution (curve a), while TC exhibits a small anodic peak at 0.68 V (curve c).…”
Section: The Voltammetric Behaviors Of Tcmentioning
confidence: 93%
“…Initially termed Aureomycin for its yellow hue, CTC was immediately recognized for its remarkable antibiotic properties and patented by American Cyanamid (7,8). In 1950, A. C. Finlay with Pfizer published the discovery of a similar antibiotic produced by Streptomyces rimosus that they named Terramycin (later renamed OTC) (9). Both compounds are broad-spectrum antibiotics and inhibit protein synthesis in bacteria by binding to the 30 S ribosomal subunit (10,11).…”
Section: Oxytetracycline (Otc)mentioning
confidence: 99%